How Gut Health Affects Polycystic Ovary Syndrome (PCOS)

How Gut Health Impacts PCOS Symptoms

Emerging research reveals that gut health significantly affects Polycystic Ovary Syndrome (PCOS) symptoms. Alterations in gut microbiota can influence insulin resistance, inflammation, and hormonal imbalances, which are key factors in PCOS. Understanding the connection between gut health and PCOS offers new avenues for managing this condition effectively.

Altered Gut Microbiota

Women with PCOS exhibit lower diversity and altered phylogenetic composition of gut microbiota compared to healthy controls. The gut microbiota is the community of microorganisms living in the digestive tract, playing a crucial role in overall health. In PCOS patients, the diversity of these microorganisms is significantly reduced. Specifically, beneficial bacterial families like Tenericutes and Bacteroidetes are less prevalent. These bacteria are essential for maintaining gut health and supporting reproductive functions.

Moreover, there are higher levels of a bacterium called Bacteroides vulgatus in PCOS patients. This bacterium is associated with several negative health impacts. Elevated Bacteroides vulgatus levels can disrupt ovarian functions, leading to menstrual irregularities and fertility issues. It also contributes to insulin resistance, a condition where the body’s cells do not respond properly to insulin, making it difficult to regulate blood sugar levels. Additionally, Bacteroides vulgatus affects bile acid metabolism. Bile acids are necessary for digesting fats and regulating metabolism, and their disruption can contribute to the metabolic problems often seen in PCOS.

Microbial Diversity and Composition

Alpha Diversity

Research indicates that PCOS patients have significantly lower alpha diversity in their gut microbiota compared to healthy controls. Alpha diversity measures the variety of species within a specific environment, in this case, the gut. 

This diversity is crucial for a healthy gut ecosystem, as a wide range of bacteria performs various beneficial functions. Lower alpha diversity, observed in PCOS patients, particularly those who are obese, means there are fewer different types of bacteria present. This reduction can lead to imbalances in gut health, affecting digestion, immunity, and overall metabolic function.

Beta Diversity

PCOS patients show significant differences in beta diversity compared to healthy individuals. Beta diversity measures the variation in microbial communities between different environments or individuals. This means that the composition of gut bacteria in PCOS patients is distinct from that of individuals without PCOS. These differences indicate that the microbial communities in the guts of PCOS patients have a unique structure and composition.

In both obese and non-obese PCOS patients, these distinct microbial patterns suggest that specific bacterial communities might influence the development and progression of PCOS. For example, certain bacteria that are more prevalent in PCOS patients may contribute to metabolic disturbances, such as insulin resistance and systemic inflammation. Understanding these differences in beta diversity helps researchers identify which bacterial species might be targets for therapeutic interventions to manage PCOS symptoms more effectively.

Specific Microbial Changes

Bacteroidetes and Firmicutes

PCOS patients often exhibit an imbalance between the two major phyla of gut bacteria: Bacteroidetes and Firmicutes. Typically, the phylum Bacteroidetes is reduced, while Firmicutes are relatively more abundant in individuals with PCOS. This imbalance is significant because Bacteroidetes are generally associated with the breakdown of complex molecules into simpler compounds, aiding in digestion and nutrient absorption.

Conversely, an overabundance of Firmicutes has been linked to increased energy extraction from food, which may contribute to obesity and metabolic issues. Specific genera within these phyla also differ between PCOS patients and healthy individuals. For instance, Lactococcus is more common in non-obese PCOS patients, while Coprococcus_2 is prevalent in obese PCOS patients. These specific microbial changes highlight the complex relationship between gut microbiota and PCOS, suggesting that different bacterial populations may influence various aspects of the syndrome.

Bacteroides vulgatus

Elevated levels of Bacteroides vulgatus are consistently found in PCOS patients. This specific bacterium is linked to several adverse health effects. Higher levels of Bacteroides vulgatus can disrupt ovarian function, leading to menstrual irregularities and fertility issues commonly seen in PCOS. 

It also contributes to insulin resistance, where the body’s cells do not respond properly to insulin, making blood sugar regulation challenging. Furthermore, Bacteroides vulgatus affects bile acid metabolism, which is essential for digesting fats and regulating metabolism. The disruption of these processes can exacerbate the metabolic issues associated with PCOS.

Metabolic and Hormonal Correlations in PCOS

Insulin Resistance and Inflammation

Altered gut microbiota in PCOS is closely linked to increased insulin resistance and systemic inflammation. Insulin resistance occurs when the body’s cells fail to respond effectively to insulin, leading to higher blood sugar levels. 

This condition is a common feature of PCOS and contributes to the difficulty many patients have in managing their weight and metabolic health. Certain gut bacteria, such as those in the families Ruminococcaceae and Streptococcaceae, show strong associations with markers of insulin resistance and inflammatory cytokines, which are signaling molecules that promote inflammation. These specific bacteria are elevated in PCOS patients, suggesting that they play a role in the metabolic disturbances and chronic inflammation that exacerbate PCOS symptoms.

Sex Hormones

Higher testosterone concentrations, a hallmark of PCOS, influence the composition of gut microbiota and associate with various metabolic and reproductive issues. Elevated testosterone levels correlate with lower bacterial diversity in the gut.

Additionally, specific microbial changes occur, including increased levels of Streptococcus and decreased levels of Bacteroidaceae. These changes in the gut microbiota link to the hormonal imbalances seen in PCOS, complicating the management of the condition and potentially worsening symptoms such as hirsutism (excessive hair growth) and acne.

Predictive and Diagnostic Potential of PCOS

Recent advancements in machine learning have shown promise in using gut microbiota data to distinguish between PCOS and non-PCOS individuals with high accuracy. These predictive models analyse specific microbial and metabolite signatures that are characteristic of PCOS. 

By identifying unique patterns in the gut microbiota, these models can potentially serve as diagnostic tools. This approach offers a non-invasive method to aid in the early detection and diagnosis of PCOS, helping healthcare providers to develop personalised treatment plans based on an individual’s gut microbiota profile.

Implications for PCOS Management

Gut health significantly impacts the severity and symptoms of PCOS. Alterations in gut microbiota, including reduced diversity and specific microbial changes, play critical roles in the development of insulin resistance, systemic inflammation, and hormonal imbalances associated with PCOS. 

Understanding these connections opens up new avenues for managing PCOS symptoms through targeted treatments aimed at restoring gut microbiota balance. Potential interventions include dietary changes, probiotics, prebiotics, and even advanced techniques like faecal microbiota transplantation, all of which show promise in improving both metabolic and reproductive health in PCOS patients.

References

1. Singh, S., Pal, N., Shubham, S., Sarma, D. K., Verma, V., Marotta, F., & Kumar, M. (2023). Polycystic Ovary Syndrome: Etiology, Current Management, and Future Therapeutics. Journal of Clinical Medicine, 12(4), 1454. https://doi.org/10.3390/jcm12041454

2. He, F. F., & Li, Y. M. (2020). Role of gut microbiota in the development of insulin resistance and the mechanism underlying polycystic ovary syndrome: a review. Journal of Ovarian Research, 13(1). https://doi.org/10.1186/s13048-020-00670-3

3. Lindheim, L., Bashir, M., Münzker, J., Trummer, C., Zachhuber, V., Leber, B., Horvath, A., Pieber, T. R., Gorkiewicz, G., Stadlbauer, V., & Obermayer-Pietsch, B. (2017b). Alterations in Gut Microbiome Composition and Barrier Function Are Associated with Reproductive and Metabolic Defects in Women with Polycystic Ovary Syndrome (PCOS): A Pilot Study. PloS One, 12(1), e0168390. https://doi.org/10.1371/journal.pone.0168390

4. Giampaolino, P., Foreste, V., Di Filippo, C., Gallo, A., Mercorio, A., Serafino, P., Improda, F. P., Verrazzo, P., Zara, G., Buonfantino, C., Borgo, M., Riemma, G., De Angelis, C., Zizolfi, B., Bifulco, G., & Della Corte, L. (2021). Microbiome and PCOS: State-of-Art and Future Aspects. International Journal of Molecular Sciences, 22(4), 2048. https://doi.org/10.3390/ijms22042048

5. Duan, L., An, X., Zhang, Y., Jin, D., Zhao, S., Zhou, R., Duan, Y., Zhang, Y., Liu, X., & Lian, F. (2021). Gut microbiota as the critical correlation of polycystic ovary syndrome and type 2 diabetes mellitus. Biomedicine & Pharmacotherapy, 142, 112094. https://doi.org/10.1016/j.biopha.2021.112094

6. Yang, Z., Fu, H., Su, H., Cai, X., Wang, Y., Hong, Y., Hu, J., Xie, Z., & Wang, X. (2022). Multi-omics analyses reveal the specific changes in gut metagenome and serum metabolome of patients with polycystic ovary syndrome. Frontiers in Microbiology, 13. https://doi.org/10.3389/fmicb.2022.1017147

7. Insenser, M., Murri, M., Del Campo, R., Martínez-García, M. N., Fernández-Durán, E., & Escobar-Morreale, H. F. (2018b). Gut Microbiota and the Polycystic Ovary Syndrome: Influence of Sex, Sex Hormones, and Obesity. ˜the œJournal of Clinical Endocrinology and Metabolism/Journal of Clinical Endocrinology & Metabolism, 103(7), 2552–2562. https://doi.org/10.1210/jc.2017-02799

8. Min, Q., Geng, H., Gao, Q., & Xu, M. (2023). The association between gut microbiome and PCOS: evidence from meta-analysis and two-sample mendelian randomization. Frontiers in Microbiology, 14. https://doi.org/10.3389/fmicb.2023.1203902

9. Zhou, L., Ni, Z., Cheng, W., Yu, J., Sun, S., Zhai, D., Yu, C., & Cai, Z. (2020). Characteristic gut microbiota and predicted metabolic functions in women with PCOS. Endocrine Connections, 9(1), 63–73. https://doi.org/10.1530/ec-19-0522

10. Bai, X., Ma, J., Wu, X., Qiu, L., Huang, R., Zhang, H., Huang, H., & Chen, X. (2023). Impact of Visceral Obesity on Structural and Functional Alterations of Gut Microbiota in Polycystic Ovary Syndrome (PCOS): A Pilot Study Using Metagenomic Analysis. Diabetes, Metabolic Syndrome and Obesity, Volume 16, 1–14. https://doi.org/10.2147/dmso.s388067

11. Jobira, B., Frank, D. N., Pyle, L., Silveira, L. J., Kelsey, M. M., Garcia-Reyes, Y., Robertson, C. E., Ir, D., Nadeau, K. J., & Cree-Green, M. (2020). Obese Adolescents With PCOS Have Altered Biodiversity and Relative Abundance in Gastrointestinal Microbiota. ˜the œJournal of Clinical Endocrinology and Metabolism/Journal of Clinical Endocrinology & Metabolism, 105(6), e2134–e2144. https://doi.org/10.1210/clinem/dgz26